General anesthesia Ma Ling Department of Anesthesiology - PowerPoint PPT Presentation

1 / 47
About This Presentation
Title:

General anesthesia Ma Ling Department of Anesthesiology

Description:

General anesthesia Ma Ling Department of Anesthesiology Shengjing Hospital, China Medical University Tel: 13386861177 What is general anesthesia? A. pain relief ... – PowerPoint PPT presentation

Number of Views:183
Avg rating:3.0/5.0
Slides: 48
Provided by: syanesthe
Category:

less

Transcript and Presenter's Notes

Title: General anesthesia Ma Ling Department of Anesthesiology


1
General anesthesia
  • Ma Ling
  • Department of Anesthesiology
  • Shengjing Hospital, China Medical University
  • Tel 13386861177

2
What is general anesthesia?
  • A. pain relief (analgesia)
  • B. blocking memory of the procedure (amnesia)
  • C. producing unconsciousness
  • D. inhibiting normal body reflexes to make
    surgery safe and easier to perform
  • E. relaxing the muscles of the body

3
Definition
  • General anesthesia is anesthetics-induced
    reversible suppression on CNS, and has the
    following manifestations
  • producing unconsciousness
  • pain relief (analgesia)
  • blocking memory of the procedure (amnesia)
  • inhibiting normal body reflexes to make surgery
    safe and easier to perform
  • relaxing the muscles of the body

4
Course of General Anesthesia
Maintenance period
IVInhale
Lost consciousness
Induction period
quickly
Recovery period
Exhale
IV
awake
5
Route of Action
Intravenous anesthetics
Inhalation anesthetics
Alveolar
blood
Central nervous system
Anesthesia
6
Inhalation anesthetics
  • Through airway
  • Maintenance (most) induction (some)
  • Most are halogenated hydrocarbons
  • Mechanism interact with the brain cell membrane,
    details are not clear

7
How to compare anesthetic potency?
  • MAC (minimum alveolar concentration)
  • ????????
  • The concentration (at 1atm) required to
    prevent movement in 50 of subjects following a
    surgical stimulus
  • Oil-gas partition coefficient
  • Anesthetic potency
  • MAC
  • MAC is also an index for depth of anesthesia

8
Inhalational anesthesia
  • Lower MAC higher potency

Elder hypotension hypothermia
hypothyroidism concurrent use of opioids
Infant pyrexia drug abuser
MAC
MAC
9
How to determine its controllability?
  • Blood-gas partition coefficient (solubility)
  • The lower the blood-gas partition coefficient
  • the easier for the partial pressure in alveolar,
    blood and brain to get equilibrium
  • the easier to control its concentration
    in brain

10
Physicochemical property
  • (1) oil-gas partition coefficient
  • anesthetic potency
    MAC
  • (2) blood-gas partition coefficient
  • controllability

reverse
reverse
reverse
11
Which has the best anesthetic potency?Which
takes effect fastest?
12
FA alveolar concentration of anestheticFI
inspired concentration of anesthetic
  • FA /FI shows the increasing rate of anesthetic
    in alveolar

13
Factors determine FA FA /FI
  • Effect of ventilation
  • Effect of concentration
  • Cardiac output
  • Blood-gas partition coefficient (solubility)
  • Alveolar-to-venous anesthetic gradient

14
Metabolism of inhalation anesthetics
  • Major eliminated by lung
  • Minor metabolized in liver
  • metabolic rate, media product and the final
    product

decide toxicity
15
Nitrous Oxide (N2O), ??
  • MAC 105, low anesthetic potency, inhalation
    conc.50-70 (FiO2gt0.3) , in combination with
    other agent
  • B/G 0.47, fast
  • Respiratory system non-irritant, no injury
  • Cardiovascular system almost no-depression
  • Diffuse hypoxia inhale 100 O2 5-10min
  • Increase cavity pressure forbidden in colon
    obstruction

16
Enflurane, ???
  • Propertiesclear colourless volatile anesthesia,
    pleasant smell
  • MAC 1.7, B/G 1.9, Metabolism 2
  • Cardiovascular Myocardial contractility reduced
  • Systemic vascular
    resistanceBP
  • Sensitivity of
    myocardium to catecholamine
  • Respiratory non-irritant dose dependent
    inhibition
  • Muscle relaxation
  • Induction and maintenance, unavailable in USA
  • Patient with epilepsy history should be avoided
    (seizure activity on EEG)

17

Isoflurane, ???
  • Properties clear colourless volatile
    anesthesia, pungent odor
  • MAC 1.15 B/G 1.4 Metabolism 0.2
  • Cardiovascular mild depression of myocardial
    contractility
  • systemic
    vascular resistanceBP
  • coronary steal
  • little
    sensitization of myocardium to Catecholamine
  • Respiratory dose dependent inhibition
  • Muscle relaxation
  • Maintanence

18
Sevoflurane, ???
  • Properties clear colourless volatile
    anesthetic pleasant smell
  • MAC 2 B/G 0.65 (rapid induction in
    children) Metabolism 2
  • Cardiovascular similar to isoflurane
  • Respiratory dosedependent inhibition, no
    irritate to airway
  • Muscle relaxation similar to isoflurane
  • Both Induction and maintenance
  • Decomposition in soda lime and when temperature
    rises

19
(No Transcript)
20
Desflurane, ???
  • Properties clear colorless volatile anesthesia
  • MAC 6.0-7.25 B/G 0.42 (very rapid onset)
    Metabolism 0.02
  • Cardiovascular similar to isoflurane but no
    coronary steal
  • Respiratory no pungent odor but irritant
  • Muscle relaxation stronger than isoflurane
  • Induction and maintenance
  • Nausea and vomiting
  • Special vaporizer, expensive

21
(No Transcript)
22
Halothane, ??
  • Properties clear colorless volatile anesthesia
    pleasant smell
  • MAC 0.75 B/G 2.4 Metabolism 20
  • Cardiovascular Myocardial contractility reduced
  • Systemic vascular
    resistanceBP
  • Increase
    sensitization of myocardium to catecholamine
  • Respiratory non-irritant pleasant smell
    dilate bronchial inhibition
  • Muscle relaxation
  • Induction and maintenance
  • Halothane associated hepatitis seldom in use
    now, unavailable in China

23
Questions
  • What are the MACs of different anesthetics?
  • What determines the anesthetic potency?
  • Which anesthetics is the best choice in induction
    of anesthesia in children?
  • Which halogenated anesthetic takes effect
    fastest?

24
  • Intravenous anesthetics

25
Ideal Intravenous anesthetic
  • Water-soluble, no pain on injection
  • Rapid onset, rapid recovery, little accumulation,
    little depression on respiratory-cardiovascular
    system. No nausea and vomiting, no interact with
    muscle relaxant, no release of histamine.

26
Intravenous anesthetics
27
Thiopentone
  • Sedationhypnosis lost consciousness
  • 2.5 4-6mg/kg
  • Onset 30s
  • Analgesic effect poor
  • CNS cerebral metabolic
    rate

  • anticonvulsant
  • Cardiovascular myocardial
    contractility

  • vasodiltation, BP
  • Respiratory VT RR
  • bronchial
    muscle tone
  • Indications induction/anticonvul
    sant/anesthesia.

28
(No Transcript)
29
Propofol, ???
  • Out-patient anesthesia
  • Induction 2mg/kg maintenance TCI/TIVA
  • Supplement to local anesthesia
  • Sedation in ICU
  • Side effect cardiovascular respiratory
    suppression, excitatory phenomenon, pain on
    injection

30
Sodium hydroxybutyrate, ????
  • Site Cortex(??)?hippocampus(??)?limbic
    system(????)
  • Normal physical sleeping
  • CirculationBP slightly increase?HR reduce
  • Respiration TV increase?frequency slow
  • IndicationInduction and maintenance
  • basal anesthesiaketamine
    (poor analgesia effect)
  • Dosage 50-100mg/kg
  • Onset 5-10min, duration45-60min

31
Questions
  • Which drug has dissociated anesthesia?
  • Which drug can depress steroid synthesis?
  • Which intravenous anesthetic can increase
    intracranial pressure?
  • What is the induction dosage of propofol?

32
Muscle relaxants(?????)
  • Skeletal muscle relaxants
  • No anesthetic effect
  • Cannot make patient lost consciousness
  • Cannot produce amnesia
  • Suitable condition for surgery
  • Avoid hazardous of deep anesthesia
  • No analgesia

33
Mechanism interfere with the normal action of
acetylcholine (ACH) at the motor end plate, block
the receptors on the postsynaptic muscle membrane
Presynaptic membrane
ACH
Postsynaptic membrane
Depolarization Muscle contraction
ACH
synaptic gap ACH
ACH
ACH
ACH
Impulse
repolarization
??????ACH
34
Classification
  • Depolarizing muscle relaxants
  • suxamethonium (Succinylcholine,
    scoline)
  • Nondepolarizing muscle relaxants
  • Pancuronium
  • Vecuronium
  • Atracurium
  • Tubocurarine

35
Depolarizing muscle relaxantSuxamethonium (????)
  • similar to acetylcholine (ACH),binding to
    receptor, depolarizing contraction
    (fasciculation)
  • cant be hydrolyzed by cholinesterase,NO
    responses to further action,flaccid-muscle
    relaxant
  • Indication tracheal intubate 1-2mg/kg
  • peak at 1min, 4-5min,
    recover at 10min
  • Side effects muscle pains
  • intraocular,
    intragastric, intracranial pressure
  • hyperkalaemia
  • Malignant hyperthermia

36
Nondepolarizing muscle relaxant
  • tubocurarine(????)
  • binding to receptor , but non-depolarizing
    compete for the receptors
  • antagonist by inhibitor of cholinesterase
    (neostigmine????) ?

37
Muscle relaxants
  • agents intubating dose onset
    action duration
  • (mg/kg)
    (min) (min)
  • Scoline 1-2
    0.5 3-8
  • ????
  • Tubocurarine 0.6 4-6
    30-40
  • ????
  • Pancuronium 0.1 3-6
    30-6
  • ????
  • Atracurium 0.6
    3-5 15-35
  • ????
  • Vecuronium 0.1
    2-3 25-30
  • ????

38
Muscle relaxants
  • ??? advantage side effect
    metabolisam histamine release
  • Scoline rapid fasciculation,K
    cholinesterase (-)
  • pressure

  • Tubocurarine asthma
    kidney ?bile ()
  • Pancuronium HR
    liver kidney bile ()
  • Atracurium Hoffmann
    Hoffmann?????? ()
  • Vecuronium
    liver kidney bile (-)
  • Cis-atracurium Hoffmann
    Hoffmann??????

39
Atracurium and cisatracurium
  • Dose intubation 0.5-0.6mg/kg
  • maintenance 0.15-0.2mg/kg
  • Time intubation 90-120s
  • duration 20-25min
  • Release histamine, hypotension
  • Spontaneous degradation in plasma, unaffected by
    liver or renal function
  • Cisatracurium more potent

40
(No Transcript)
41
Rocuronium
  • Dose intubation 0.6-0.7mg/kg
  • maintenance 0.15-0.2mg/kg
  • Time intubation 90-100s
  • duration 20-30min
  • Can be used for rapid sequence intubation

42
(No Transcript)
43
Vecuronium
  • Dose intubation 0.1mg/kg
  • maintenance 0.02-0.03mg/kg
  • Time intubation 90-120s
  • duration 15-20min
  • No histamine release, can be used in patients
    with asthma

44
Pancuronium
  • Dose intubation 0.15-0.2mg/kg
  • maintenance 0.1mg/kg
  • Time intubation 100-120s
  • duration 10-15min
  • Hypertension and tachycardia may occur
  • Long-acting

45
(No Transcript)
46
Questions
  • What is the mechanism of the action of muscle
    relaxants? And the classification of them?
  • Which drug can induce malignant hyperthermia?

47
Thank you!
Write a Comment
User Comments (0)
About PowerShow.com